GGHC
TMCI icon

Gilder Gagnon Howe & Co’s Treace Medical Concepts TMCI Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,708
Closed -$69.3K – 308
2023
Q2 		$69.3K Buy
+2,708
New +$69.9K ﹤0.01% 286

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gilder Gagnon Howe & Co's TMCI Position: Q3 2023 in Review

Gilder Gagnon Howe & Co sold out of Treace Medical Concepts (TMCI) in Q3 2023, closing a stake of 2,708 shares — an estimated $69.3K sold.

Gilder Gagnon Howe & Co first reported a position in TMCI in Q2 2023 and held it in 1 quarter. The position peaked at $69.3K in Q2 2023. 123 funds tracked by Wall St. Rank hold TMCI as of Q3 2023.

  • Gilder Gagnon Howe & Co reported no remaining Treace Medical Concepts position as of Q3 2023 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 2,708 Treace Medical Concepts shares in Q3 2023, an estimated $69.3K.
  • Gilder Gagnon Howe & Co first reported a position in Treace Medical Concepts in Q2 2023 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's Treace Medical Concepts position peaked at $69.3K in Q2 2023.
  • 123 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2023.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2023, filed 14 Nov 2023.